These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 23705633)
1. Protein kinase inhibitors: breakthrough medicines and the next generation. Sawyer TK; Wu JC; Sawyer JR; English JM Expert Opin Investig Drugs; 2013 Jun; 22(6):675-8. PubMed ID: 23705633 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of intrinsic and acquired resistance to kinase-targeted therapies. Bagrodia S; Smeal T; Abraham RT Pigment Cell Melanoma Res; 2012 Nov; 25(6):819-31. PubMed ID: 22883054 [TBL] [Abstract][Full Text] [Related]
3. Editorial: Recent Advances in the Field of Kinases and Kinase Inhibitors. Huang Z; Lee MH Curr Pharm Des; 2017 Nov; 23(29):4207-4208. PubMed ID: 29231803 [No Abstract] [Full Text] [Related]
4. Is there a future for Aurora kinase inhibitors for anticancer therapy? Carpinelli P; Moll J Curr Opin Drug Discov Devel; 2009 Jul; 12(4):533-42. PubMed ID: 19562649 [TBL] [Abstract][Full Text] [Related]
5. The mammalian target of rapamycin kinase and tumor growth inhibition. Boulay A; Lane HA Recent Results Cancer Res; 2007; 172():99-124. PubMed ID: 17607938 [No Abstract] [Full Text] [Related]
6. Kinase-targeted libraries: the design and synthesis of novel, potent, and selective kinase inhibitors. Akritopoulou-Zanze I; Hajduk PJ Drug Discov Today; 2009 Mar; 14(5-6):291-7. PubMed ID: 19121409 [TBL] [Abstract][Full Text] [Related]
8. New class of kinase inhibitors poised to join the anticancer arsenal. Opar A Nat Rev Drug Discov; 2012 Nov; 11(11):819-20. PubMed ID: 23123929 [No Abstract] [Full Text] [Related]
9. Next generation of mammalian target of rapamycin inhibitors for the treatment of cancer. Nelson V; Altman JK; Platanias LC Expert Opin Investig Drugs; 2013 Jun; 22(6):715-22. PubMed ID: 23544840 [TBL] [Abstract][Full Text] [Related]
10. PI3K inhibitors for cancer treatment: where do we stand? Maira SM; Stauffer F; Schnell C; García-Echeverría C Biochem Soc Trans; 2009 Feb; 37(Pt 1):265-72. PubMed ID: 19143644 [TBL] [Abstract][Full Text] [Related]
11. Molecule of the month. Temsirolimus. Drug News Perspect; 2007; 20(6):406. PubMed ID: 17925894 [No Abstract] [Full Text] [Related]
12. Cancer drug development. Preface. Sawyers CL; Mellinghoff IK Curr Top Microbiol Immunol; 2012; 355():v-vi. PubMed ID: 23227490 [No Abstract] [Full Text] [Related]
13. Small molecule inhibitors of protein kinases in cancer- how to overcome resistance. Griffith R; Brown MN; McCluskey A; Ashman LK Mini Rev Med Chem; 2006 Oct; 6(10):1101-10. PubMed ID: 17073710 [TBL] [Abstract][Full Text] [Related]
14. Benzofuran Small Molecules as Potential Inhibitors of Human Protein Kinases. A Review. Kwiecień H; Goszczyńska A; Rokosz P Curr Pharm Des; 2016; 22(7):879-94. PubMed ID: 26648467 [TBL] [Abstract][Full Text] [Related]
15. Issues and progress with protein kinase inhibitors for cancer treatment. Dancey J; Sausville EA Nat Rev Drug Discov; 2003 Apr; 2(4):296-313. PubMed ID: 12669029 [TBL] [Abstract][Full Text] [Related]
16. Kinase dysfunction and kinase inhibitors. London CA Vet Dermatol; 2013 Feb; 24(1):181-7.e39-40. PubMed ID: 23331696 [TBL] [Abstract][Full Text] [Related]
17. Specific delivery of kinase inhibitors in nonmalignant and malignant diseases. van Beuge MM; Poelstra K; Prakash J Expert Opin Drug Deliv; 2012 Jan; 9(1):59-70. PubMed ID: 22111941 [TBL] [Abstract][Full Text] [Related]
18. The development and therapeutic potential of protein kinase inhibitors. Cohen P Curr Opin Chem Biol; 1999 Aug; 3(4):459-65. PubMed ID: 10419844 [TBL] [Abstract][Full Text] [Related]